share_log

Regeneron Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director POON CHRISTINE A

SEC ·  Jan 6 13:10

Summary by Moomoo AI

Regeneron Pharmaceuticals insider POON CHRISTINE A acquired a total of 180 shares of Common Stock in two separate transactions. On 12/20/2024, 14 shares were granted at $0 per share. Subsequently, on 01/02/2025, an additional 166 shares were acquired, also at no cost.Following these transactions, POON CHRISTINE A's direct ownership increased to 2,352 shares. The acquisitions were reported as grants or awards, indicating they may be part of executive compensation or incentive plans. The transactions are marked as in progress, suggesting potential future related events or filings.
Regeneron Pharmaceuticals insider POON CHRISTINE A acquired a total of 180 shares of Common Stock in two separate transactions. On 12/20/2024, 14 shares were granted at $0 per share. Subsequently, on 01/02/2025, an additional 166 shares were acquired, also at no cost.Following these transactions, POON CHRISTINE A's direct ownership increased to 2,352 shares. The acquisitions were reported as grants or awards, indicating they may be part of executive compensation or incentive plans. The transactions are marked as in progress, suggesting potential future related events or filings.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Related Stocks Related Stocks
    Symbol Mini Chart Price
    Sana Biotechnology
    SANA
    -- 4.300
    Vir Biotechnology
    VIR
    -- 12.480
    Silo Pharma
    SILO
    -- 1.710
    Compass Therapeutics
    CMPX
    -- 1.860
    NLS Pharmaceutics
    NLSP
    -- 2.4100

    Unlock the Full List